KORTUC Pivotal Phase 2 study is commenced in the UK

  • R&D

A pivotal Phase 2 study for locally advanced/recurrent breast cancer to evaluate the efficacy of KORTUC was started in the Royal Marsden Hospital and other Cancer Centers across the UK.

Further information can be found below
•       Phase 2 study